Boostrix
PATIENT INFORMATION
The patient, parent, or guardian should be:
- informed of the potential benefits and risks of immunization with BOOSTRIX (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) .
- informed about the potential for adverse reactions that have been temporally associated with administration of BOOSTRIX (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) or other vaccines containing similar components.
- instructed to report any adverse events to their healthcare provider.
- given the Vaccine Information Statements, which are required by the National Childhood Vaccine Injury Act of 1986 to be given prior to immunization. These materials are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/nip).
Last reviewed on RxList: 7/21/2011
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Boostrix Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
